Factor II deficiency
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hypoprothrombinemia (OR 1.676, 95% CI 1.275-2.203) and prothrombin time (PT) prolongation (OR 2.050, 95% CI 1.398-3.005) were significantly associated with NMTT-cephalosporins, whereas bleeding was not (OR 1.359, 95% CI 0.920-2.009).
|
31623191 |
2019 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prothrombin may therefore be associated like FV with both a bleeding condition (prothrombin deficiency) and a thrombophilic state (some dysprothrombinemias).
|
29063359 |
2018 |
Factor II deficiency
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
|
25242243 |
2014 |
Factor II deficiency
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
Congenital prothrombin deficiency: an update.
|
23852823 |
2013 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that occurs in approximately 1 in 1-2 million people.
|
19141155 |
2008 |
Factor II deficiency
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This is the first report of the molecular basis of prothrombin deficiency in Indian patients and we suggest the eponym 'Prothrombin Vellore 1' for Ala362 --> Thr mutation.
|
15892853 |
2005 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly.
|
14962227 |
2004 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
The primary effect of this defect appears to be destabilization of the circulating prothrombin, creating a moderate hypoprothrombinemia.
|
14629473 |
2003 |
Factor II deficiency
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Therefore, transgenic expression of human prothrombin is sufficient for the rescue of the lethality found for prothrombin deficiency in mice.
|
12529749 |
2002 |
Factor II deficiency
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Prothrombin carora: hypoprothrombinaemia caused by substitution of Tyr-44 by Cys.
|
10354129 |
1999 |
Factor II deficiency
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Cases with a parallel decrease in prothrombin activity and antigen should not be considered as examples of hypoprothrombinemia.
|
9863703 |
1998 |
Factor II deficiency
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The abnormal prothrombin gene of an Italian patient with a severe bleeding tendency and hypoprothrombinemia was selected for study and compared with the prothrombin genes of healthy controls.
|
9134629 |
1997 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
Automated fluorescence-based DNA sequence analysis of amplified genomic DNA was used to define prothrombin gene regions from a patient with severe functional hypoprothrombinemia and little detectable prothrombin antigen.
|
9351523 |
1997 |
Factor II deficiency
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A patient with a severe bleeding tendency and hypoprothrombinemia (Factor II activity 2%, Factor II antigen 5%) was screened for the presence of alterations in his prothrombin gene.
|
7740448 |
1994 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.
|
1334372 |
1992 |
Factor II deficiency
|
0.400 |
Biomarker
|
disease |
BEFREE |
We suggest that the propositus is heterozygous for an abnormal prothrombin and heterozygous for true prothrombin deficiency.
|
6409139 |
1983 |